These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38262332)

  • 1. Inadequate harms reporting among randomized controlled trials cited as supporting evidence in the AAOS management of hip fractures in older adults clinical practice guideline recommendations.
    Howard C; Sell T; Abraham C; Anderson JM; Norris B; Anderson RM; Vu TK; Vassar M; Checketts JX
    Injury; 2024 Mar; 55(3):111326. PubMed ID: 38262332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries.
    Anderson JM; Howard C; Hardin J; Phelps CR; Hanson C; Anderson RM; Vassar M; Checketts JX
    J Shoulder Elbow Surg; 2022 Dec; 31(12):e620-e627. PubMed ID: 35961499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harms reporting in randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guidelines for glenohumeral osteoarthritis.
    Chauhan A; Kotlier JL; Thompson AA; Mayfield CK; Abu-Zahra M; Hwang NM; Bolia IK; Petrigliano FA; Liu JN
    J Shoulder Elbow Surg; 2024 Mar; 33(3):e109-e115. PubMed ID: 37898417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transparency Matters: Assessing Harms Reporting Compliance in Randomized Controlled Trials Underpinning the AAOS Clinical Practice Guideline for Anterior Cruciate Ligament Injuries.
    Brown J; DiCicco L; Shepard S; Hughes G; Bennett S; Anderson JM; Hanson C; Heckler M
    Am J Sports Med; 2024 Jul; 52(9):2244-2249. PubMed ID: 39101735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate Reporting of Complications in Randomized Controlled Trials Cited as Supporting Evidence Underpinning AAOS CPG Recommendations for Hip and Knee Osteoarthritis: Application of the CONSORT Harms Checklist.
    Anderson JM; Howard C; Staggs J; Steele R; Strasser T; Small T; Vassar M; Checketts JX
    J Arthroplasty; 2022 Dec; 37(12):2466-2472.e2. PubMed ID: 35709908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Evidence Underpinning the American Academy of Orthopedic Surgeons Knee Osteoarthritis Clinical Practice Guidelines.
    Waters P; Anderson R; Anderson JM; Scott J; Detweiler B; Streck S; Hartwell M; Torgerson T; Vassar M
    Sports Health; 2023; 15(1):11-25. PubMed ID: 35915571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Complication Reporting for Randomized Controlled Trials Contained in Clinical Practice Guidelines for the Management of Carpal Tunnel Syndrome.
    Ozdag Y; Hayes DS; Callahan C; El Koussaify J; Warnick EP; Foster BK; Klena JC; Grandizio LC
    J Hand Surg Glob Online; 2023 Nov; 5(6):779-783. PubMed ID: 38106925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harms Reporting in Randomized Controlled Trials Underpinning the American Academy of Orthopaedic Surgeons Clinical Practice Guidelines for Distal Radius Fractures.
    Thompson AA; Iyer A; Mayfield CK; Petrigliano FA; Nicholson LT; Liu JN
    J Hand Surg Am; 2023 Apr; ():. PubMed ID: 37097262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Analysis of the Evidence Underpinning the American Academy Orthopaedic Surgery Pediatrics Clinical Practice Guidelines.
    Batioja KLE; Nguyen T; Anderson JM; Detweiler B; Checketts J; Torgerson T; Hartwell M; Vassar M
    J Pediatr Orthop; 2022 Feb; 42(2):e218-e223. PubMed ID: 34739437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of Complications in Rhinoplasty Randomized Controlled Trials: An Analysis Using the CONSORT Extension for Harms Checklist.
    Hemmerich C; Corcoran A; Johnson AL; Wilson A; Orris O; Arellanes R; Vassar M
    Otolaryngol Head Neck Surg; 2024 Jul; 171(1):81-89. PubMed ID: 38613190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
    Kumar S; Mohammad H; Vora H; Kar K
    J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension.
    Hodkinson A; Kirkham JJ; Tudur-Smith C; Gamble C
    BMJ Open; 2013 Sep; 3(9):e003436. PubMed ID: 24078752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria.
    Carmichael K; Nolan SJ; Weston J; Tudur Smith C; Marson AG
    Epilepsy Res; 2015 Aug; 114():106-13. PubMed ID: 26088893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review.
    Hadi MA; McHugh GA; Conaghan PG
    Evid Based Med; 2017 Oct; 22(5):170-177. PubMed ID: 28866634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.
    Speich B; Mann E; Schönenberger CM; Mellor K; Griessbach AN; Dhiman P; Gandhi P; Lohner S; Agarwal A; Odutayo A; Puebla I; Clark A; Chan AW; Schlussel MM; Ravaud P; Moher D; Briel M; Boutron I; Schroter S; Hopewell S
    JAMA Netw Open; 2023 Jun; 6(6):e2317651. PubMed ID: 37294569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review.
    Gorrell LM; Engel RM; Brown B; Lystad RP
    Spine J; 2016 Sep; 16(9):1143-51. PubMed ID: 27241208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.
    Xie T; Zhang Z; Qi C; Lu M; Zhang X; Li J; Shen L; Peng Z
    Oncologist; 2021 Dec; 26(12):e2239-e2246. PubMed ID: 34396642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trials behind level A recommendations in obstetric practice bulletins: compliance with CONSORT statement.
    Chauhan SP; Berghella V; Sanderson M; Siddiqui D; Hendrix NW; Magann EF
    Am J Perinatol; 2009 Jan; 26(1):69-80. PubMed ID: 18979412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.